Ophthalmology · 2025
Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-Analysis.
СтатьяСистематический обзорМетаанализПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gallo Afflitto Gabriele, Fabozzi Lorenzo, Palmieri Filomena, Anastasi Marco, Pant Nayana, Kaymaz Orkun, Surico Pier Luigi, Maurino Vincenzo, Aiello Francesco, Nucci Carlo
Аннотация
TOPIC: To evaluate whether pars plana vitrectomy (PPV) increases the risk of ocular hypertension (OHT) and glaucoma, with particular focus on lens status as a risk modifier.
CLINICAL RELEVANCE: Ocular hypertension and glaucoma are major complications that can threaten vision and require lifelong management. Although PPV is a standard treatment for vitreoretinal disease, concerns exist about its long-term effects on intraocular pressure and glaucoma, particularly in pseudophakic eyes, where the natural lens barrier is absent. No clear quantitative synthesis currently informs risk stratification in this context.
METHODS: The protocol for this systematic review and meta-analysis was prospectively registered in International Prospective Register of Systematic Reviews (CRD42024541683), and data reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies were randomized or nonrandomized comparative studies reporting OHT or glaucoma after PPV in adults. We last searched Ovid MEDLINE, Ovid EMBASE, and Web of Science on May 25, 2024. Two reviewers independently conducted screening, data extraction, and Risk of Bias in Non-randomized Studies-of Interventions (ROBINS-I) risk of bias assessment. Meta-analyses were performed using generalized linear mixed-effects models. Publication bias and heterogeneity were assessed. The ROBINS-I tool was used to assess the risk of bias in nonrandomized studies, and the certainty of evidence was evaluated using Grading of Recommendations, Assessment, Development, and Evaluation. Numbers needed to treat for harm (NNTH) were calculated using standard formulas as recommended in the Cochrane Handbook to enhance the clinical interpretability of the results.
RESULTS: Forty-one observational studies (54 006 patients, 54 021 eyes) were included. The pooled absolute risk was 5.6% (95% confidence interval [CI]: 3.1-9.9; I2 = 94.6%; low certainty) for post-PPV OHT, and 3.9% (95% CI: 2.0-7.2; I2 = 94.4%; low certainty). Pseudophakic eyes had a threefold higher odds of OHT compared to phakic eyes (odds ratio [OR], 3.2; 95% CI: 1.4-9.9; I2 = 75.1%; NNTH, 8; very low certainty) and nearly 12-fold higher odds of glaucoma (OR, 11.8; 95% CI: 4.2-33.6; I2 = 0%; NNTH, 10; moderate certainty).
CONCLUSION: Pars plana vitrectomy is associated with clinically meaningful risk of OHT and glaucoma, especially in pseudophakic eyes. Despite limitations from nonrandomized data and heterogeneity, these findings highlight lens status as a key modifier of post-PPV risk and support tailored surgical planning and postoperative monitoring.
FINANCIAL DISCLOSURES: The author(s) have no proprietary or commercial interest in any materials discussed in this article.
CLINICAL RELEVANCE: Ocular hypertension and glaucoma are major complications that can threaten vision and require lifelong management. Although PPV is a standard treatment for vitreoretinal disease, concerns exist about its long-term effects on intraocular pressure and glaucoma, particularly in pseudophakic eyes, where the natural lens barrier is absent. No clear quantitative synthesis currently informs risk stratification in this context.
METHODS: The protocol for this systematic review and meta-analysis was prospectively registered in International Prospective Register of Systematic Reviews (CRD42024541683), and data reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies were randomized or nonrandomized comparative studies reporting OHT or glaucoma after PPV in adults. We last searched Ovid MEDLINE, Ovid EMBASE, and Web of Science on May 25, 2024. Two reviewers independently conducted screening, data extraction, and Risk of Bias in Non-randomized Studies-of Interventions (ROBINS-I) risk of bias assessment. Meta-analyses were performed using generalized linear mixed-effects models. Publication bias and heterogeneity were assessed. The ROBINS-I tool was used to assess the risk of bias in nonrandomized studies, and the certainty of evidence was evaluated using Grading of Recommendations, Assessment, Development, and Evaluation. Numbers needed to treat for harm (NNTH) were calculated using standard formulas as recommended in the Cochrane Handbook to enhance the clinical interpretability of the results.
RESULTS: Forty-one observational studies (54 006 patients, 54 021 eyes) were included. The pooled absolute risk was 5.6% (95% confidence interval [CI]: 3.1-9.9; I2 = 94.6%; low certainty) for post-PPV OHT, and 3.9% (95% CI: 2.0-7.2; I2 = 94.4%; low certainty). Pseudophakic eyes had a threefold higher odds of OHT compared to phakic eyes (odds ratio [OR], 3.2; 95% CI: 1.4-9.9; I2 = 75.1%; NNTH, 8; very low certainty) and nearly 12-fold higher odds of glaucoma (OR, 11.8; 95% CI: 4.2-33.6; I2 = 0%; NNTH, 10; moderate certainty).
CONCLUSION: Pars plana vitrectomy is associated with clinically meaningful risk of OHT and glaucoma, especially in pseudophakic eyes. Despite limitations from nonrandomized data and heterogeneity, these findings highlight lens status as a key modifier of post-PPV risk and support tailored surgical planning and postoperative monitoring.
FINANCIAL DISCLOSURES: The author(s) have no proprietary or commercial interest in any materials discussed in this article.